Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02488408
Title Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine in Patients With AML
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors BerGenBio AS
Indications

acute myeloid leukemia

Therapies

Cytarabine

Bemcentinib

Age Groups: adult
Covered Countries USA | DEU

Facility Status City State Zip Country Details
University of Iowa Hospitals and Clinics Recruiting Iowa City Iowa 52242 United States Details
James Cancer Hospital & Solove Research Institute Recruiting Columbus Ohio 43210 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Universitätsklinikum Frankfurt, Medizinische Klinik II Recruiting Frankfurt 60596 Germany Details
University Medical Center Hamburg-Eppendorf Martinistrasse Recruiting Hamburg 20246 Germany Details
Medizinische Hochschule Hannover Recruiting Hannover 30625 Germany Details
Universitätsklinikum Ulm, Oberer Eselsberg, Zentrum für Innere Medizin III Recruiting Ulm 89081 Germany Details
Haukeland University Hospital Recruiting Bergen 5021 Norway Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field